Delivery Order SPE2DB25D2204-SPE2DB25FTGLP
- Not listed
- The Defense Logistics Agency awarded a $27,538.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on April 21, 2025, with completion scheduled for April 22, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger prime vendor agreement with DLA Troop Support Medical. Orencia (abatacept) is a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, with the...
- The Defense Logistics Agency awarded a delivery order valued at $11,739.22 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price contract with no set-aside designation, executed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic disease-modifying antirheumatic drug used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $3,748.72 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant medication used primarily in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $25,022.24 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic disease-modifying antirheumatic drug used to treat...
- The Defense Logistics Agency awarded a $6,473.76 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the same address. Orencia (abatacept)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,144.19 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. Orencia (abatacept) is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for Orencia ClickJect 125 mg/ml with a ceiling value of $9,679.46. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance will be...
- The Defense Logistics Agency awarded a $20,468.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply...
- The Defense Logistics Agency awarded a $10,338.74 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL pharmaceutical products on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orencia ClickJect is a biologic medication used in the treatment of rheumatoid arthritis and other...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $38,612.57 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on July 31, 2025, with completion scheduled for August 1, 2025. This competitive award utilizes firm fixed-price pricing and represents a child contract under the contractor's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGLPDelivery Order
The Defense Logistics Agency awarded a $37,218.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on May 8, 2025, with an ultimate completion date of May 9, 2025. This non-competitive award, issued from the prime contractor's location in Conshohocken, Pennsylvania, represents a single delivery order fulfillment under an existing contract vehicle. Orencia (abatacept) is a biologic immunosuppressant medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, products that align with AmerisourceBergen's established role as a critical pharmaceutical supplier to federal healthcare systems. This delivery order derives from AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems worldwide. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive procurement requirements across multiple therapeutic domains, positioning it as a primary vendor for the Department of Defense's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.2k | 5/8/25 |